SEC Comment Letter for Capstone Holding Corp. (CAPS) (CIK 0000887151) (CAPS) — Jun 17, 2011

Capstone Holding Corp. (CAPS) (CIK 0000887151)
Date: June 17, 2011 · CIK: 0000887151 · Accession: 0000000000-11-037224

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-33560

Date

June 17, 2011

Author

/s/ Joel Parker

Form

UPLOAD

Company

Capstone Holding Corp. (CAPS) (CIK 0000887151)

Letter

June 17, 2011 Via E-mail John M. Holliman, III Executive Chairman Capstone Therapeutics Corp. 1275 West Washington Street, Suite 101 Tempe, AZ 85281

Re: Capstone Therapeutics Corp. Item 4.01 Form 8-K Filed June 10, 2011 File No. 001-33560

Dear Mr. Holliman: We have completed our review of your f iling. We remind you that our comments or changes to disclosure in res ponse to our comments do not for eclose the Commission from taking any action with respect to the company or th e filing and the company may not assert staff comments as a defense in any proceeding ini tiated by the Commission or any person under the federal securities laws of the United States. We urge all pers ons who are responsible for the accuracy and adequacy of the disclosure in the fi ling to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ Joel Parker
J o e l P a r k e r A c c o u n t i n g B r a n c h C h i e f

Show Raw Text

June 17, 2011

Via E-mail
John M. Holliman, III
Executive Chairman
Capstone Therapeutics Corp.
1275 West Washington Street, Suite 101 Tempe, AZ 85281

Re: Capstone Therapeutics Corp.
Item 4.01 Form 8-K   Filed June 10, 2011
  File No. 001-33560

Dear Mr. Holliman:
 We have completed our review of your f iling.  We remind you that our comments or
changes to disclosure in res ponse to our comments do not for eclose the Commission from taking
any action with respect to the company or th e filing and the company may not assert staff
comments as a defense in any proceeding ini tiated by the Commission or any person under the
federal securities laws of the United States.  We urge all pers ons who are responsible for the
accuracy and adequacy of the disclosure in the fi ling to be certain that the filing includes the
information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
  /s/ Joel Parker
        J o e l  P a r k e r          A c c o u n t i n g  B r a n c h  C h i e f

SecProbe.io